Phase II Trial of Curcumin in Patients with Advanced Pancreatic Cancer
Purpose: Pancreatic cancer is almost always lethal, and the only U.S. Food and Drug Administration–approved therapies for it, gemcitabine and erlotinib, produce objective responses in <10% of patients. We evaluated…